
Skinner is a General Partner at MarsBio, an early-stage biotechnology investment fund, and as senior advisor to Minicircle, a gene therapy startup. Skinner is additionally a co-founder and senior advisor to Dark Matter, a human genomics and personalized medicine startup.
Skinner is also the co-founder and chairman of RavenGraph, an AI startup building Graph Neural Network machine learning technology with applications to genomics and longevity.
In 2012, Skinner founded Exosphere, a learning and problem-solving community that conducted intensive educational programs & startup boot camps focused on deep tech & science entrepreneurship. He has also served as a mentor for Start-Up Chile and the Estonia-based Cocoon startup mentoring program.
Skinner has more than 2.500 hours of experience as a lecturer and group facilitator in more than 25 cities, with 1.700 students from more than 50 countries. Through his extensive people work, he developed a novel Jungian model of psychological type built on an evolutionary game-theoretical understanding of competitive bias and error preferences.
He has broad experience in business, finance, technology, and politics, as a startup founder, consultant to NASDAQ companies, and a strategist and speechwriter to the early congressional campaigns of U.S. Senator John Boozman.
He has spent most of his adult life living abroad, 11 years in South America—Brazil and Chile, and since 2019, has lived near Barcelona.
"We are a tool using species - biotechnology is the greatest tool yet discovered. It will be the key to our survival here on Earth, and key to our transformation into a spacefaring civilization."

Mark is a General Partner at MarsBio, an early-stage biotechnology investment fund. He is also the co-founder and a managing partner at Olivon Advisors, an early-stage Venture investment firm.
Through his family office, Six Toes Ventures, Mark has invested in over 100 companies across enterprise SaaS, blockchain, gaming, biotech and deep tech. He has also participated in dozens of token sales and NFTs. He is a multiple unicorn investor in crypto, medtech and natural resources.
Mark actively advises companies on investor relations, capital markets structuring and strategic planning.
While living as an expat for 10 years in New Zealand, Mark created the global macro blog, CapitalistExploits and formed an investment syndicate called Seraph. The syndicate consists of private investors and family offices from over a dozen countries. As a group, Seraph represented investments of over $70 mm in 50+ companies and organized and ran investor meet ups in 16+ countries over 5 years.
Mark received a Bachelor of Science degree in Public Health from Northern Illinois University in 1990. He is a dual-citizen of both the U.S. and New Zealand.
"The future of longevity lies in precision medicine, AI-driven therapies, and regenerative biology. By decoding aging at the molecular level, we'll extend healthy human lifespan beyond 120 years, transforming society and redefining what it means to live fully."

Rob is an entrepreneur and inventor from Atlanta, GA. He graduated Y Combinator's Summer 2012 class with Level RF, an innovative radio technology used to provide internet access to the developing world. Rob currently serves as Executive Chairman at Soylent, a company he founded in 2013.
While CEO of the company, Soylent won BevNet's "Best New Product" award, and is currently available in over 15,000 retail locations. Rob has been honored as a top entrepreneur by Goldman Sachs, and was listed on both Forbes' and Inc.'s "30 Under 30" lists.
"We have witnessed the Golden Age of aviation. The world is now smaller. We have lived through the Golden Age of computing. A universe of information is now available at your fingertips. These are nothing. Nothing compared to the wonders to be brought by the Golden Age of Biology that is now upon us. The world will change. Everything will change. From the skies above down to your fingertips."